What is the long-term trend for Ingevity's restricted marketable debt and other securities (note 6)?

Over 5 years (2020 to 2025), Ingevity's restricted marketable debt and other securities (note 6) has grown at a 0.6% compound annual growth rate (CAGR), from $81.5M to $84M.

Ingevity NGVT Restricted marketable debt and other securities (Note 6)

Restricted marketable debt and other securities (Note 6) at other companies

Blue Owl Technology Finance Corp.OTF

$1B-44.4%

Credit AcceptanceCACC

$109.4M+0.4%

Fulton FinancialFULT

$119.95M-11.9%

1st Source CorporationSRCE

$294.15M+22.1%

Dime Community Bancshares DCOM

$63.66M-5.0%

Columbia Financial, Inc.CLBK

$490M+31.3%

Other financials

Income statement

See full

Revenue$258.0M+4.1%

Gross profit$116.4M+4.0%

Net income$59.8M+192%

EPS (diluted)$1.66+196%

Balance sheet

See full

Cash & equivalents$95.4M+5.0%

Total debt$1.4B-9.0%

Total equity$38.9M-83.4%

Total assets$1.7B-19.7%

Cash flow

See full

Operating cash flow-$2.0M-108%

CapEx$10.3M+3.0%

Free cash flow-$12.3M-180%

Valuation

See full

Market cap$2.53B+73.9%

Enterprise value$3.8B+32.4%

P/S2.1×+0.9×

Profitability

See full

Gross margin39.3%+1.5pp

Net margin-10.6%-4.1pp

FCF margin20.3%+12.6pp

Returns & leverage

See full

Return on equity-93.5%+1.2pp

Debt / equity35.1×+28.7×

Current ratio1.4×-0.6×

Where this comes from

Reported directly by Ingevity in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsAtFairValue.

The official record: Ingevity’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingevity's restricted marketable debt and other securities (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ingevity's restricted marketable debt and other securities (note 6)?: Ingevity (NGVT) reported restricted marketable debt and other securities (note 6) of $84.7M in Q1 2026.
How has Ingevity's restricted marketable debt and other securities (note 6) changed year-over-year?: Ingevity's restricted marketable debt and other securities (note 6) increased by 4.2% year-over-year, from $81.3M to $84.7M.
What is the long-term trend for Ingevity's restricted marketable debt and other securities (note 6)?: Over 5 years (2020 to 2025), Ingevity's restricted marketable debt and other securities (note 6) has grown at a 0.6% compound annual growth rate (CAGR), from $81.5M to $84M.